Research Investments
OPKO strategically invests in private pharmaceutical companies with high potential for growth and producing products of significant medical value.
Cocrystal Discovery, Inc. is a privately held biopharmaceutical company focusing on the discovery and development of novel antiviral drugs using a combination of protein structure-based approaches. The Cocrystal technology can also be applied to other targets of medical importance. For more information on Cocrystal, please visit their website at http://www.cocrystal.com
Sorrento Therapeutics, Inc. is a privately held biotechnology company with a proprietary platform technology for the generation of fully human monoclonal antibodies. For more information on Sorrento, please visit their website at http://www.sorrentotherapeutics.com